Skip to Content

United Laboratories International Holdings Ltd ULIHF

Morningstar Rating
$1.09 +0.20 (22.01%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ULIHF is trading at a 728% premium.
Price
$1.10
Fair Value
$2.86
Uncertainty
Very High
1-Star Price
$9.65
5-Star Price
$4.47
Economic Moat
Jwl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ULIHF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.89
Day Range
$1.091.09
52-Week Range
$0.891.09
Bid/Ask
$0.90 / $1.20
Market Cap
$1.98 Bil
Volume/Avg
101 / 109

Key Statistics

Price/Earnings (Normalized)
5.22
Price/Sales
1.02
Dividend Yield (Trailing)
5.14%
Dividend Yield (Forward)
5.14%
Total Yield
5.14%

Company Profile

United Laboratories International Holdings Ltd is a drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Majority of the company's sales are generated in China, followed by Europe, India and other countries.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Value
Total Number of Employees
15,000

Comparables

Valuation

Metric
ULIHF
02877
01672
Price/Earnings (Normalized)
5.225.63
Price/Book Value
1.100.720.42
Price/Sales
1.021.2017.84
Price/Cash Flow
4.295.30
Price/Earnings
ULIHF
02877
01672

Financial Strength

Metric
ULIHF
02877
01672
Quick Ratio
1.602.9716.51
Current Ratio
2.083.3516.58
Interest Coverage
49.41419.36−1,693.40
Quick Ratio
ULIHF
02877
01672

Profitability

Metric
ULIHF
02877
01672
Return on Assets (Normalized)
13.68%10.81%−5.34%
Return on Equity (Normalized)
23.45%13.25%−5.59%
Return on Invested Capital (Normalized)
20.01%12.92%−9.56%
Return on Assets
ULIHF
02877
01672
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
VmrydyygsZmwz$83.1 Bil
Merck KGaA ADR
MKKGY
CgfmqdklSwrjx$73.3 Bil
Haleon PLC ADR
HLN
NvzflwjNzm$39.7 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
BsgvjmpMvpmk$19.0 Bil
Viatris Inc
VTRS
RmlkzktQgwc$14.1 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
HvdzctfcRxwlp$13.2 Bil
Catalent Inc
CTLT
VbrrbxpyRygwm$10.5 Bil
Perrigo Co PLC
PRGO
CmsmvsyxpNtpc$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
KgmqnhfmVjxcqv$3.6 Bil
Curaleaf Holdings Inc
CURLF
DjfjqxsVhqmy$3.2 Bil

Sponsor Center